Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study

Lifestyle changes are causing an exponential increase in the prevalence of obesity and metabolic syndrome (MetS) worldwide. The most frequent complications of these are the development of diabetes (T2D) and cardiovascular disease (CVD). Accurate tools are needed to classify the cardiovascular risk (...

Full description

Bibliographic Details
Main Authors: Blanca Riquelme-Gallego, Laura García-Molina, Naomi Cano-Ibáñez, Francisco Andújar-Vera, Sheila González-Salvatierra, Cristina García-Fontana, Aurora Bueno-Cavanillas, Manuel Muñoz-Torres, Beatriz García-Fontana
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/14/2991
_version_ 1797433257177907200
author Blanca Riquelme-Gallego
Laura García-Molina
Naomi Cano-Ibáñez
Francisco Andújar-Vera
Sheila González-Salvatierra
Cristina García-Fontana
Aurora Bueno-Cavanillas
Manuel Muñoz-Torres
Beatriz García-Fontana
author_facet Blanca Riquelme-Gallego
Laura García-Molina
Naomi Cano-Ibáñez
Francisco Andújar-Vera
Sheila González-Salvatierra
Cristina García-Fontana
Aurora Bueno-Cavanillas
Manuel Muñoz-Torres
Beatriz García-Fontana
author_sort Blanca Riquelme-Gallego
collection DOAJ
description Lifestyle changes are causing an exponential increase in the prevalence of obesity and metabolic syndrome (MetS) worldwide. The most frequent complications of these are the development of diabetes (T2D) and cardiovascular disease (CVD). Accurate tools are needed to classify the cardiovascular risk (CVR) in the MetS population. In recent years, numerous biomarkers of bone metabolism have been associated with CVR. The aim of this study was to determine the levels of undercarboxylated osteocalcin (ucOC) in a cohort of patients with MetS and to analyse its association with MetS parameters and CVR as well as with T2D prevalence. A longitudinal study was conducted in which a MetS population was followed for one year. Weight change, adherence to the Mediterranean diet (MedDiet), ucOC levels, MetS parameters and CVR were analysed and CVR was calculated using different scores. Our results showed a decrease of CVR associated with a better adherence to the MetDiet resulting in higher HDL-C and ucOC levels though the improvement of MetS risk factors. This bone protein appeared as a potential biomarker to classify CVR in the MetS population, especially for MetS patients without prevalent T2D. Furthermore, ucOC serum levels could be good predictors of T2D prevalence.
first_indexed 2024-03-09T10:14:26Z
format Article
id doaj.art-744013507f884e73b6f4003686ce0e67
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T10:14:26Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-744013507f884e73b6f4003686ce0e672023-12-01T22:32:17ZengMDPI AGNutrients2072-66432022-07-011414299110.3390/nu14142991Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot StudyBlanca Riquelme-Gallego0Laura García-Molina1Naomi Cano-Ibáñez2Francisco Andújar-Vera3Sheila González-Salvatierra4Cristina García-Fontana5Aurora Bueno-Cavanillas6Manuel Muñoz-Torres7Beatriz García-Fontana8Department of Preventive Medicine and Public Health, University of Granada, 18016 Granada, SpainDepartment of Preventive Medicine and Public Health, University of Granada, 18016 Granada, SpainDepartment of Preventive Medicine and Public Health, University of Granada, 18016 Granada, SpainDepartment of Computer Science and Artificial Intelligence, University of Granada, 18071 Granada, SpainInstituto de Investigación Biosanitaria (ibs.GRANADA), 18014 Granada, SpainInstituto de Investigación Biosanitaria (ibs.GRANADA), 18014 Granada, SpainDepartment of Preventive Medicine and Public Health, University of Granada, 18016 Granada, SpainInstituto de Investigación Biosanitaria (ibs.GRANADA), 18014 Granada, SpainInstituto de Investigación Biosanitaria (ibs.GRANADA), 18014 Granada, SpainLifestyle changes are causing an exponential increase in the prevalence of obesity and metabolic syndrome (MetS) worldwide. The most frequent complications of these are the development of diabetes (T2D) and cardiovascular disease (CVD). Accurate tools are needed to classify the cardiovascular risk (CVR) in the MetS population. In recent years, numerous biomarkers of bone metabolism have been associated with CVR. The aim of this study was to determine the levels of undercarboxylated osteocalcin (ucOC) in a cohort of patients with MetS and to analyse its association with MetS parameters and CVR as well as with T2D prevalence. A longitudinal study was conducted in which a MetS population was followed for one year. Weight change, adherence to the Mediterranean diet (MedDiet), ucOC levels, MetS parameters and CVR were analysed and CVR was calculated using different scores. Our results showed a decrease of CVR associated with a better adherence to the MetDiet resulting in higher HDL-C and ucOC levels though the improvement of MetS risk factors. This bone protein appeared as a potential biomarker to classify CVR in the MetS population, especially for MetS patients without prevalent T2D. Furthermore, ucOC serum levels could be good predictors of T2D prevalence.https://www.mdpi.com/2072-6643/14/14/2991metabolic syndromecardiovascular riskdiabetesosteocalcinMediterranean diet
spellingShingle Blanca Riquelme-Gallego
Laura García-Molina
Naomi Cano-Ibáñez
Francisco Andújar-Vera
Sheila González-Salvatierra
Cristina García-Fontana
Aurora Bueno-Cavanillas
Manuel Muñoz-Torres
Beatriz García-Fontana
Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
Nutrients
metabolic syndrome
cardiovascular risk
diabetes
osteocalcin
Mediterranean diet
title Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
title_full Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
title_fullStr Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
title_full_unstemmed Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
title_short Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
title_sort undercarboxylated osteocalcin a promising target for early diagnosis of cardiovascular and glycemic disorders in patients with metabolic syndrome a pilot study
topic metabolic syndrome
cardiovascular risk
diabetes
osteocalcin
Mediterranean diet
url https://www.mdpi.com/2072-6643/14/14/2991
work_keys_str_mv AT blancariquelmegallego undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT lauragarciamolina undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT naomicanoibanez undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT franciscoandujarvera undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT sheilagonzalezsalvatierra undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT cristinagarciafontana undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT aurorabuenocavanillas undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT manuelmunoztorres undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy
AT beatrizgarciafontana undercarboxylatedosteocalcinapromisingtargetforearlydiagnosisofcardiovascularandglycemicdisordersinpatientswithmetabolicsyndromeapilotstudy